The West Virginia Racing Commission heard the pros and cons of race-day furosemide use Sept. 17 and pledged to examine the steps necessary to implement mandatory administration of the anti-bleeding drug by third-party vets.
Salix, British Champions Day offer obstacles for Breeders' Cup. read blog
The Kentucky HBPA's statement wasn't the one it hoped to make. read blog
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
Kentucky Gov. Steve Beshear Aug. 30 said regulations designed to reform some aspects of the state's equine medication policy will be implemented despite action by a legislative committee that found them deficient.
Two national organizations said Aug. 28 they find it "troubling" factions in Kentucky horse racing are opposing medication regulations proposed by the Kentucky Horse Racing Commission but shot down by a legislative committee.
The California Horse Racing Board's Medication and Track Safety Committee has endorsed proposed changes in race-day administration of furosemide.
The West Virginia Racing Commission has officially scheduled a meeting for Sept. 17 to take comments from industry representatives on the use of furosemide, also known as Salix or Lasix, on race day.
A Kentucky legislative subcommittee, in a surprise vote, found regulations governing equine medication "deficient" Aug. 27, just one week before they are scheduled to take effect.
Furosemide will be the only medication permitted on race day in Kentucky effective Sept. 4, and the drug will be administered by regulatory veterinarians only under new Kentucky Horse Racing Commission rules.
In a change designed to win support of its Reformed Racing Medication Rules, The Jockey Club has added a provision governing regulatory administration of furosemide on race day.
There may be plenty of data out there on trainer performance, but for owners, selecting a conditioner involves much more than numbers, according to an owner and trainer that have worked together for about 15 years.
A race-day ban of Salix in graded stakes for 2-year-olds would be extended to listed stakes as part of a new evaluation program.
The West Virginia Racing Commission in late summer or early fall plans to hold a fact-finding meeting on use of furosemide on race day, officials said Aug. 4.
- By Tom LaMarra
The majority of National Horsemen's Benevolent and Protective Association affiliates have adopted resolutions calling for continued regulated use of furosemide on race day.
- By Steve Haskin
Steve and Lenny discuss the sophomore horses and who to watch during the second part of the year. They also talk about the fillies, New York Times, California stakes names, and Salix. watch video
While many of racing's major issues were discussed at the July 25 meeting of the board of directors of the Association of Racing Commissioners International, the agenda called for few decisions to be made.
Some of racing's most notable owners pledged to race 2-year-olds of 2012 without furosemide and adjunct bleeder medications, TOBA announced July 19.
Hollywood Casino at Penn National Race Course is the first of three Pennsylvania Thoroughbred tracks to require administration of race-day furosemide by third-party veterinarians.
The Association of Racing Commissioners International is reassessing its policy supporting race-day administration of furosemide, but also indicated much needs to be done before any change is made.
During a June 29 meeting that showed the battle over race-day furosemide is escalating, supporters ripped their opponents and vowed to take their case -- that the medication is good for the racehorse -- to the public.
Did you miss the live show? Listen now to the archived, on demand, version. Listen Now!
- By Tom LaMarra
Regulators around the country are examining the Kentucky Horse Racing Commission's move to phase out race-day furosemide in graded and listed stakes beginning in 2014, but there doesn't appear to be a rush to follow suit.
The controversial subject of furosemide, the anti-bleeder medication widely used in North American racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m. EDT, Tuesday, June 26.
- By Tom LaMarra
The Thoroughbred Racing Associations has endorsed a policy for medication reform that has been supported by many industry stakeholders but so far acted upon piecemeal in various jurisdictions.
Some foreign racing organizations issued statements June 14 backing action by the Kentucky Horse Racing Commission to phase out use of race-day furosemide in graded and listed stakes over three years beginning Jan. 1, 2014.
The Kentucky Horse Racing Commission, by a 7-5 vote with one abstention June 13, approved an administrative regulation that would ban the use of furosemide on race day in graded and listed stakes over a three-year period.
In a development that figures to play out in other racing states, two New York senators said June 12 the anti-bleeding medication furosemide should not be banned on race day.
In advance of an expected vote by the Kentucky Horse Racing Commission June 13, the American Graded Stakes Committee reaffirmed its desire to ban all race-day medication in graded stakes for 2-year-olds.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
A new law that allows for an expansion of racetrack card clubs in Minnesota also permits the Minnesota Racing Commission to set threshold testing levels for therapeutic medications used in racehorses.
The Kentucky Horse Racing Commission has scheduled a town hall meeting for June 5 to discuss the proposed three-year phase-out of the race-day drug furosemide.
There doesn't seem to be any middle ground in the debate over the anti-bleeding drug furosemide, and it seems doubtful the two sides will come together any time soon.
The Kentucky Horse Racing Commission May 16 kept alive a proposed regulation to phase out over three years race-day furosemide for graded and listed stakes, but not before the Equine Drug Research Council voted to reject it.
The Jockey Club May 15 released an eight-page letter it submitted to the New York State Racing and Wagering Board the previous day in regard to use of the race-day medication and furosemide and other related issues.
The Thoroughbred Owners and Breeders Association is the latest organization to respond to the New York State Racing and Wagering Board with its opinions on the use of the anti-bleeding medication furosemide on race day.
The Kentucky Horse Racing Commission confirmed it will discuss but not take final action May 16 on a proposal for the three-year phase-out of race-day furosemide in graded and listed stakes.
Darby Dan Farms owner John Phillips has been appointed to the Kentucky Horse Racing Commission as a replacement for John Ward Jr., who recently was hired as executive director of the regulatory agency.
The racing industry is closer to uniformity in drug regulations and penalties than many admit, but agreement on race-day anti-bleeding drugs in a "toxic" environment will require some heavy lifting, officials said May 2.
New York State Racing and Wagering Board chairman John Sabini says it's time for a fresh look at the state's race-day medication policy.
Members of Congress April 30 heard of problems in the Thoroughbred racing industry--most of them related to equine medication--but stopped short of a full endorsement of federal intervention.
Thoroughbred racing got further bruises April 30 during an allegation-ridden congressional hearing into equine health and medication issues that furthered a call for federal intervention--at least on some level.
Owners have clean, quick solution to Salix: Stop giving it to your racehorses read blog
An effort to make Kentucky the first state to ban the anti-bleeder medication furosemide for racing purposes failed April 16 when the state's Horse Racing Commission voted 7-7 not to approve it.
The Kentucky Horsemen's Benevolent and Protective Association has requested Gov. Steve Beshear not to sign any request to implement on an emergency basis a ban on race-day use of furosemide.
During April 10 meeting in Lexington, TOBA board of trustee members discussed other ways owners can be involved in ending race-day medication use.
- By Tom LaMarra
The Jockey Club officially released its "Reformed Racing Medication Rules" March 30, but broad adoption of the policies hinges on action by regulators in all racing jurisdictions.
Members of the National Thoroughbred Racing Association Safety and Integrity Alliance have been given the updated code of standards for 2012, officials said March 12.
- By Eric Mitchell
- Northeast Region, West Region, Kentucky, Thoroughbred Owners and Breeders Association
The American Graded Stakes Committee is taking a more realistic approach to implementing a pilot program to ban race-day medication for juvenile graded stakes. It acknowledges regulatory change will take time.
Breeders' Cup Ltd. has reaffirmed its plan to ban race-day medications in World Championships races for 2-year-olds this year, despite recent action by the American Graded Stakes Committee to delay a similar ban.
Most Popular Stories
- McCraken to Miss Tampa Bay Derby With Ankle Strain
- Steve Haskin's Derby Dozen - February 28, 2017
- Arrogate Headed to Dubai World Cup
- Favorable Reviews of Fasig-Tipton Under Tack Show
- Five Share Fastest Time in Fasig-Tipton Sale Works
- Honorable Duty Latest Big Winner for Walsh
- Finger Lakes Horsemen Agree to Deal to Keep Track Open
- Conquest Mo Money Still Undefeated, Sunland Derby Next
- Girvin Upsets Risen Star Stakes
- Broken Pelvis Cause of Charismatic's Death